Skip to main content
Top
Published in: Familial Cancer 1/2023

05-08-2022 | Colectomy | Original Article

Endoscopic management of familial adenomatous polyposis targeting colorectal lesions greater than 5 mm in size: a single-center retrospective study

Authors: Tatsuro Murano, Hiroaki Ikematsu, Kensuke Shinmura, Kei Okumura, Takeshi Kuwata, Mineko Ushiama, Teruhiko Yoshida, Kenji Takashima, Keiichiro Nakajo, Tomohiro Kadota, Yusuke Yoda, Yasuhiro Oono, Tomonori Yano

Published in: Familial Cancer | Issue 1/2023

Login to get access

Abstract

Preserving the colon while preventing colorectal cancer is challenging in patients with familial adenomatous polyposis. Although prophylactic colectomy is the current standard of care, some patients with familial adenomatous polyposis may wish to postpone colectomy as long as polyposis can be managed by endoscopic resection. This study examined our endoscopic management and prognostic results for patients with familial adenomatous polyposis who refused to undergo colectomy. We retrospectively analyzed the data of 12 patients with familial adenomatous polyposis treated at our hospital between January 1995 and December 2020. All patients opted to postpone prophylactic colectomy although they had significant polyp burdens and underwent endoscopic management, in which colorectal polyps sized > 5 mm were thoroughly resected during baseline colonoscopies and subsequently, newly arising colorectal polyps sized > 5 mm were periodically resected during surveillance colonoscopies. Patients (median age, 33 years) were followed up for a median of 5.2 years. The median number of colonoscopies and resected lesions per patient was 2 and 14 at baseline as well as, 9 and 32 during surveillance, respectively. The interval between colonoscopies was 1.0 and 7.0 months for baseline and surveillance, respectively. The colons of all 12 patients were preserved, and no invasive colorectal cancer developed. In 10 patients, 35 cases of high-grade dysplasia were observed and managed by endoscopic resection. Repeated endoscopic resection of colorectal polyps sized > 5 mm with appropriate surveillance may be an alternative form of endoscopic management for patients with familial adenomatous polyposis wishing to postpone colectomy.
Literature
Metadata
Title
Endoscopic management of familial adenomatous polyposis targeting colorectal lesions greater than 5 mm in size: a single-center retrospective study
Authors
Tatsuro Murano
Hiroaki Ikematsu
Kensuke Shinmura
Kei Okumura
Takeshi Kuwata
Mineko Ushiama
Teruhiko Yoshida
Kenji Takashima
Keiichiro Nakajo
Tomohiro Kadota
Yusuke Yoda
Yasuhiro Oono
Tomonori Yano
Publication date
05-08-2022
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 1/2023
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-022-00308-x

Other articles of this Issue 1/2023

Familial Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine